Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
| NCT ID | NCT02609776 |
| Title | Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer (CHRYSALIS) |
| Acronym | CHRYSALIS |
| Recruitment | Active, not recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Janssen Research & Development, LLC |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA | GBR | FRA | ESP | CAN | AUS |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Duarte | California | United States | Details | |||
| La Jolla | California | United States | Details | |||
| Orange | California | United States | Details | |||
| Santa Monica | California | United States | Details | |||
| West Hollywood | California | United States | Details | |||
| Tampa | Florida | United States | Details | |||
| Chicago | Illinois | United States | Details | |||
| Bethesda | Maryland | United States | Details | |||
| Boston | Massachusetts | United States | Details | |||
| Detroit | Michigan | United States | Details | |||
| Rochester | Minnesota | United States | Details | |||
| Saint Louis | Missouri | United States | Details | |||
| New York | New York | United States | Details | |||
| Portland | Oregon | United States | Details | |||
| Philadelphia | Pennsylvania | United States | Details | |||
| Houston | Texas | United States | Details | |||
| Fairfax | Virginia | United States | Details | |||
| Camperdown | Australia | Details | ||||
| Heidelberg | Australia | Details | ||||
| Kogarah | Australia | Details | ||||
| Murdoch | Australia | Details | ||||
| Woolloongabba | Australia | Details | ||||
| Toronto | Ontario | Canada | Details | |||
| Beijing | China | Details | ||||
| Changchun | China | Details | ||||
| Changsha | China | Details | ||||
| Chengdu | China | Details | ||||
| Chongqing | China | Details | ||||
| Guangzhou | China | Details | ||||
| Hangzhou | China | Details | ||||
| Hefei | China | Details | ||||
| Nanchang | China | Details | ||||
| Nanjing | China | Details | ||||
| Wuhan | China | Details | ||||
| Zhengzhou | China | Details | ||||
| Bordeaux | France | Details | ||||
| Dijon | France | Details | ||||
| Lyon Cedex 8 | France | Details | ||||
| Marseille | France | Details | ||||
| Paris | France | Details | ||||
| Saint-Herblain Cedex | France | Details | ||||
| Villejuif Cedex | France | Details | ||||
| Chuo Ku | Japan | Details | ||||
| Hyogo | Japan | Details | ||||
| Kashiwa | Japan | Details | ||||
| Kurume | Japan | Details | ||||
| Nagoya-Shi | Japan | Details | ||||
| Niigata | Japan | Details | ||||
| Osaka | Japan | Details | ||||
| Tokyo | Japan | Details | ||||
| Wakayama | Japan | Details | ||||
| Yonago | Japan | Details | ||||
| Cheongju-si | Korea, Republic of | Details | ||||
| Goyang-si | Korea, Republic of | Details | ||||
| Incheon | Korea, Republic of | Details | ||||
| Seongnam-si | Korea, Republic of | Details | ||||
| Seoul | Korea, Republic of | Details | ||||
| A Coruna | Spain | Details | ||||
| Barcelona | Spain | Details | ||||
| Madrid | Spain | Details | ||||
| Malaga | Spain | Details | ||||
| Santander | Spain | Details | ||||
| Seville | Spain | Details | ||||
| Kaohsiung | Taiwan | Details | ||||
| Taichung | Taiwan | Details | ||||
| Taipei City | Taiwan | Details | ||||
| Taipei | Taiwan | Details | ||||
| Manchester | United Kingdom | Details | ||||
| Newcastle upon Tyne | United Kingdom | Details | ||||
| Sutton | United Kingdom | Details |